331 related articles for article (PubMed ID: 27166994)
1. Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies.
Houghton J; Hadd AG; Zeigler R; Haynes BC; Latham GJ
J Vis Exp; 2016 Apr; (110):e53836. PubMed ID: 27166994
[TBL] [Abstract][Full Text] [Related]
2. Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens.
Hadd AG; Houghton J; Choudhary A; Sah S; Chen L; Marko AC; Sanford T; Buddavarapu K; Krosting J; Garmire L; Wylie D; Shinde R; Beaudenon S; Alexander EK; Mambo E; Adai AT; Latham GJ
J Mol Diagn; 2013 Mar; 15(2):234-47. PubMed ID: 23321017
[TBL] [Abstract][Full Text] [Related]
3. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.
Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS; Lawson DH; Delman KA; El-Rayes BF; Wilson MM; Sullivan HC; Morrison AS; Balci S; Adsay NV; Gal AA; Sica GL; Saxe DF; Mann KP; Hill CE; Khuri FR; Rossi MR
J Mol Diagn; 2016 Mar; 18(2):299-315. PubMed ID: 26801070
[TBL] [Abstract][Full Text] [Related]
4. Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.
Karnes HE; Duncavage EJ; Bernadt CT
Cancer Cytopathol; 2014 Feb; 122(2):104-13. PubMed ID: 24227699
[TBL] [Abstract][Full Text] [Related]
5. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
6. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.
Choudhary A; Mambo E; Sanford T; Boedigheimer M; Twomey B; Califano J; Hadd A; Oliner KS; Beaudenon S; Latham GJ; Adai AT
BMC Med Genomics; 2014 Nov; 7():62. PubMed ID: 25395014
[TBL] [Abstract][Full Text] [Related]
8. Quality metrics for enhanced performance of an NGS panel using single-vial amplification technology.
Barua S; Hsiao S; Clancy E; Freeman C; Mansukhani M; Fernandes H
J Clin Pathol; 2023 Dec; 77(1):46-53. PubMed ID: 36376073
[TBL] [Abstract][Full Text] [Related]
9. [Feasibility of amplicon-based targeted next-generation sequencing of colorectal cancer in endoscopic biopsies].
Wang YJ; Jiang RR; Liu HJ; Zhang B; Ye F; Bu H
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):499-504. PubMed ID: 29996313
[No Abstract] [Full Text] [Related]
10. Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing.
Ståhlberg A; Krzyzanowski PM; Egyud M; Filges S; Stein L; Godfrey TE
Nat Protoc; 2017 Apr; 12(4):664-682. PubMed ID: 28253235
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
[TBL] [Abstract][Full Text] [Related]
12. A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.
van den Akker J; Mishne G; Zimmer AD; Zhou AY
BMC Genomics; 2018 Apr; 19(1):263. PubMed ID: 29665779
[TBL] [Abstract][Full Text] [Related]
13. Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissue.
Verrienti A; Pecce V; Abballe L; Ramundo V; Falcone R; Inanloo Nigi Jak F; Brunelli C; Fadda G; Bosco D; Ascoli V; Carletti R; Di Gioia C; Grani G; Sponziello M
Endocrine; 2020 Aug; 69(2):451-455. PubMed ID: 32506194
[TBL] [Abstract][Full Text] [Related]
14. Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform.
Morris SM; Subramanian J; Gel ES; Runger GC; Thompson EJ; Mallery DW; Weiss GJ
PLoS One; 2018; 13(4):e0196556. PubMed ID: 29702695
[TBL] [Abstract][Full Text] [Related]
15. Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumour specimens.
Rathi V; Wright G; Constantin D; Chang S; Pham H; Jones K; Palios A; Mclachlan SA; Conron M; McKelvie P; Williams R
Pathology; 2017 Jan; 49(1):75-82. PubMed ID: 27913044
[TBL] [Abstract][Full Text] [Related]
16. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
[TBL] [Abstract][Full Text] [Related]
17. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
[TBL] [Abstract][Full Text] [Related]
18. Test Feasibility of Next-Generation Sequencing Assays in Clinical Mutation Detection of Small Biopsy and Fine Needle Aspiration Specimens.
Zheng G; Tsai H; Tseng LH; Illei P; Gocke CD; Eshleman JR; Netto G; Lin MT
Am J Clin Pathol; 2016 May; 145(5):696-702. PubMed ID: 27247373
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
20. Systematic evaluation of PAXgene® tissue fixation for the histopathological and molecular study of lung cancer.
Southwood M; Krenz T; Cant N; Maurya M; Gazdova J; Maxwell P; McGready C; Moseley E; Hughes S; Stewart P; Salto-Tellez M; Groelz D; Rassl D;
J Pathol Clin Res; 2020 Jan; 6(1):40-54. PubMed ID: 31571426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
